A biotech startup engaged in the research and commercialization of new materials. In addition to planning and developing over 200 CBD products, it has succeeded in the industry's first research into nano-CBD formulations that dramatically enhance CBD absorption efficiency. In May 2022, it raised approximately 150 million JPY in Series A funding. CBD products are already distributed to over 500 stores nationwide, including medical institutions.
FACT BOX
- Source: PR TIMES
- Category: Event
- Organizations: M&N’s CBD
- Dates in source: 2026 SPRING